Literature DB >> 19687292

Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.

Jun-Xu Li1, Alison Unzeitig, Martin A Javors, Kenner C Rice, Wouter Koek, Charles P France.   

Abstract

Very little is known about constitutive activity in vivo. This study examined whether constitutive activity and inverse agonism contribute to discriminative stimulus effects of drugs acting at serotonin (5-HT)(2A) receptors. Rats were trained to discriminate between saline and either 0.56 mg/kg 5-HT(2) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), 1.0 mg/kg 5-HT(2A) receptor antagonist ketanserin, or 0.1 mg/kg purported 5-HT(2A) receptor inverse agonist (R)-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907). Discriminative control was established with each drug after 33 to 35 sessions. MDL100907 and ketanserin did not occasion DOM lever responding but attenuated the discriminative stimulus effects of DOM. DOM did not occasion responding on the drug-associated lever in rats discriminating MDL100907 or ketanserin, but attenuated the discriminative stimulus effects of both drugs. Ketanserin and ritanserin occasioned MDL100907-lever responding, whereas rats discriminating ketanserin responded only partially on the drug-associated lever after receiving MDL100907, ritanserin, or the alpha(1)-adrenergic antagonist prazosin. Combining prazosin with MDL100907 or ritanserin resulted in near-complete ketanserin-lever responding, indicating that the ketanserin stimulus involves both 5-HT(2A) and alpha(1)-adrenergic receptors. Administration of p-chlorophenylalanine methyl ester, then fenfluramine, significantly decreased cortical 5-HT, enhanced sensitivity to the discriminative stimulus effects of DOM, and occasioned partial MDL100907-lever responding. Collectively, these results show that DOM and MDL100907 discriminative stimulus effects are mediated by 5-HT(2A) receptors and that ketanserin discriminative stimulus effects involve both 5-HT(2A) and alpha(1)-adrenergic receptors. Results in 5-HT-depleted rats further suggest that the discriminative stimulus effects of MDL100907 might involve antagonism of endogenous 5-HT and/or inverse agonism at 5-HT(2A) receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687292      PMCID: PMC2775261          DOI: 10.1124/jpet.109.157560

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  37 in total

1.  Novel actions of inverse agonists on 5-HT2C receptor systems.

Authors:  K A Berg; B D Stout; J D Cropper; S Maayani; W P Clarke
Journal:  Mol Pharmacol       Date:  1999-05       Impact factor: 4.436

Review 2.  Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.

Authors:  Richard A Bond; Ad P Ijzerman
Journal:  Trends Pharmacol Sci       Date:  2006-01-06       Impact factor: 14.819

Review 3.  The classification of seven transmembrane receptors in recombinant expression systems.

Authors:  T Kenakin
Journal:  Pharmacol Rev       Date:  1996-09       Impact factor: 25.468

4.  Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.

Authors:  E L Barker; R S Westphal; D Schmidt; E Sanders-Bush
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

5.  Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro.

Authors:  F Orallo; E Rosa; T García-Ferreiro; M Campos-Toimil; M I Cadavid; M I Loza
Journal:  Gen Pharmacol       Date:  2000-08

6.  Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys.

Authors:  Jun-Xu Li; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2007-11-09       Impact factor: 4.030

7.  Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.

Authors:  R A Glennon; R Young; J A Rosecrans
Journal:  Eur J Pharmacol       Date:  1983-07-22       Impact factor: 4.432

8.  Discriminative stimulus properties of DOM and several molecular modifications.

Authors:  R A Glennon; R Young; J A Rosecrans
Journal:  Pharmacol Biochem Behav       Date:  1982-04       Impact factor: 3.533

9.  Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit.

Authors:  S E Welsh; A G Romano; J A Harvey
Journal:  Psychopharmacology (Berl)       Date:  1998-05       Impact factor: 4.530

10.  The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.

Authors:  P B Silverman; B T Ho
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  8 in total

1.  Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.

Authors:  Martilias Farrell; Sharon Rosenzweig-Lipson; Ellen Walker
Journal:  Psychopharmacology (Berl)       Date:  2010-06-05       Impact factor: 4.530

2.  Tolerance and cross-tolerance to the antinociceptive effects of oxycodone and the imidazoline I2 receptor agonist phenyzoline in adult male rats.

Authors:  David A Thorn; Yanan Zhang; Jun-Xu Li
Journal:  Psychopharmacology (Berl)       Date:  2017-03-17       Impact factor: 4.530

3.  Role of intracellular Ca2+ signaling in the antinociceptive and discriminative stimulus effects of the imidazoline I2 receptor agonist 2-BFI in rats.

Authors:  Justin N Siemian; Yanyan Qiu; Yanan Zhang; Jun-Xu Li
Journal:  Psychopharmacology (Berl)       Date:  2017-08-19       Impact factor: 4.530

4.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Modification of the behavioral effects of morphine in rats by serotonin 5-HT₁A and 5-HT₂A receptor agonists: antinociception, drug discrimination, and locomotor activity.

Authors:  Jun-Xu Li; Aparna P Shah; Sunny K Patel; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2012-09-20       Impact factor: 4.530

6.  Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.

Authors:  Jun-Xu Li; Wouter Koek; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

7.  Mechanisms of imidazoline I2 receptor agonist-induced antinociception in rats: involvement of monoaminergic neurotransmission.

Authors:  Justin N Siemian; Kaixuan Wang; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

8.  Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.

Authors:  William E Fantegrossi; Bradley W Gray; Jessica M Bailey; Douglas A Smith; Martin Hansen; Jesper L Kristensen
Journal:  Psychopharmacology (Berl)       Date:  2014-09-17       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.